Zhou Tingan, Park Young-Kyoung, Fu Jing, Hapeta Piotr, Klemm Cinzia, Ledesma-Amaro Rodrigo
Department of Bioengineering, Imperial College Centre for Synthetic Biology, Bezos Centre for Sustainable Protein, UKRI Engineering Biology Mission Hub on Microbial Food, Imperial College London, London, SW7 2AZ, UK.
Department of Natural Product Biosynthesis, Max Planck Institute for Chemical Ecology, 07745, Jena, Germany.
Biotechnol Biofuels Bioprod. 2025 Jan 7;18(1):1. doi: 10.1186/s13068-024-02598-y.
Crocetin is a multifunctional apocarotenoid natural product derived from saffron, holding significant promises for protection against various diseases and other nutritional applications. Historically, crocetin has been extracted from saffron stigmas, but this method is hindered by the limited availability of high-quality raw materials and complex extraction processes. To overcome these challenges, metabolic engineering and synthetic biology can be applied to the sustainable production of crocetin.
We constructed a Yarrowia lipolytica strain using hybrid promoters and copy number adjustment, which was able to produce 2.66 g/L of β-carotene, the precursor of crocetin. Next, the crocetin biosynthetic pathway was introduced, and we observed both the production and secretion of crocetin. Subsequently, the metabolite profiles under varied temperatures were studied and we found that low temperature was favorable for crocetin biosynthesis in Y. lipolytica. Therefore, a two-step temperature-shift fermentation strategy was adopted to optimize yeast growth and biosynthetic enzyme activity, bringing a 2.3-fold increase in crocetin titer. Lastly, fermentation media was fine-tuned for an optimal crocetin output of 30.17 mg/L, bringing a 51% higher titer compared with the previous highest report in shake flasks. Concomitantly, we also generated Y. lipolytica strains capable of achieving substantial zeaxanthin production, yielding 1575.09 mg/L, doubling the previous highest reported titer.
Through metabolic engineering and fermentation optimization, we demonstrated the first de novo biosynthesis of crocetin in the industrial yeast Yarrowia lipolytica. In addition, we achieved a higher crocetin titer in flasks than all our known reports. This work not only represents a high production of crocetin, but also entails a significant simultaneous zeaxanthin production, setting the stage for sustainable and cost-effective production of these valuable compounds.
藏红花素是一种源自藏红花的多功能类胡萝卜素天然产物,在预防各种疾病及其他营养应用方面具有重大前景。历史上,藏红花素是从藏红花柱头中提取的,但这种方法受到优质原材料供应有限和提取过程复杂的阻碍。为克服这些挑战,可将代谢工程和合成生物学应用于藏红花素的可持续生产。
我们利用杂交启动子和拷贝数调整构建了一株解脂耶氏酵母菌株,该菌株能够产生2.66 g/L的藏红花素前体β-胡萝卜素。接下来,引入了藏红花素生物合成途径,我们观察到了藏红花素的产生和分泌。随后,研究了不同温度下的代谢物谱,我们发现低温有利于解脂耶氏酵母中藏红花素的生物合成。因此,采用两步变温发酵策略来优化酵母生长和生物合成酶活性,使藏红花素产量提高了2.3倍。最后,对发酵培养基进行了微调,以实现30.17 mg/L的最佳藏红花素产量,与摇瓶中之前报道的最高产量相比,产量提高了51%。同时,我们还构建了解脂耶氏酵母菌株,能够大量生产玉米黄质,产量达到1575.09 mg/L,是之前报道的最高产量的两倍。
通过代谢工程和发酵优化,我们首次在工业酵母解脂耶氏酵母中实现了藏红花素的从头生物合成。此外,我们在摇瓶中获得了比所有已知报道都更高的藏红花素产量。这项工作不仅代表了藏红花素的高产,还同时实现了玉米黄质的大量生产,为这些有价值化合物的可持续和经济高效生产奠定了基础。